Table 1 Demographic and clinical characteristics of the study population according to suppression status, N = 253

Age at ART initiation (years)

2.00 (1–5)

Current age (years)

8.8 (2.99)

Weight at ART initiation (kg)

24.12 (7.24)

ART duration (months

64.0 (37–83)

Sex

 Female

134 (56.8)

9 (52.9)

143 (56.52)

0.758^*

 Male

102 (43.2)

8 (47.1)

110 (43.48)

WHO stage^a

 Stage I

38 (16.1)

5 (29.4)

43 (17.00)

0.577^*

 Stage II

43 (18.2)

3 (17.7)

46 (18.18)

 Stage III

116 (49.2)

7 (41.2)

123 (48.62)

 Stage IV

39 (16.5)

2 (11.8)

41 (16.21)

Adherence

 Good

97 (41.1)

1 (5.9)

98 (38.74)

0.003^**

 Poor

139 (58.9)

16 (94.1)

155 (61.26)

Regimen

 First-line

235 (99.6)

16 (94)

251 (99.21)

0.130^**

 Second-line

1 (0.4)

1 (5.9)

2(0.79)